drugset
drugset / Trial / NCT01572610

A Glomerular Filtration Rate (GFR) Measuring Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

NCT01572610 ↗

Phase 2 Terminated 11 enrolled Kyowa Kirin, Inc.
NaSingle-groupOpen-labelTreatment

Summary

A Phase 2 glomerular filtration rate (GFR) measuring study of RTA 402 in Chronic kidney disease (CKD) patients with type 2 diabetes mellitus.

Timeline

Start
2012-02
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bardoxolone methyl Small molecule — Oral

Indications

chronic kidney disease type 2 diabetes mellitus